Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 13 | 2023 | 2143 | 0.960 |
Why?
|
| Cutis Laxa | 1 | 2023 | 29 | 0.850 |
Why?
|
| Insecticide-Treated Bednets | 2 | 2022 | 70 | 0.810 |
Why?
|
| Biomedical Technology | 1 | 2024 | 210 | 0.760 |
Why?
|
| Systemic Inflammatory Response Syndrome | 6 | 2022 | 622 | 0.670 |
Why?
|
| Spinal Diseases | 1 | 2023 | 561 | 0.610 |
Why?
|
| Remote Sensing Technology | 1 | 2019 | 93 | 0.600 |
Why?
|
| Reagent Strips | 1 | 2017 | 40 | 0.560 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2017 | 87 | 0.540 |
Why?
|
| Joint Instability | 1 | 2023 | 802 | 0.510 |
Why?
|
| Deglutition | 1 | 2017 | 208 | 0.500 |
Why?
|
| Hypocalcemia | 1 | 2017 | 205 | 0.500 |
Why?
|
| Malaria | 3 | 2022 | 1246 | 0.490 |
Why?
|
| Meningitis, Bacterial | 1 | 2017 | 222 | 0.480 |
Why?
|
| Family Characteristics | 2 | 2019 | 1001 | 0.470 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2021 | 1019 | 0.460 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2023 | 1480 | 0.440 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1603 | 0.420 |
Why?
|
| Malaria, Cerebral | 2 | 2012 | 136 | 0.410 |
Why?
|
| Airway Obstruction | 1 | 2017 | 665 | 0.390 |
Why?
|
| Ventilators, Mechanical | 3 | 2023 | 291 | 0.370 |
Why?
|
| Administration, Inhalation | 10 | 2023 | 1153 | 0.370 |
Why?
|
| Inpatients | 2 | 2023 | 2565 | 0.340 |
Why?
|
| Leukocytes | 1 | 2017 | 2027 | 0.320 |
Why?
|
| Fear | 1 | 2017 | 1500 | 0.300 |
Why?
|
| Coma | 1 | 2010 | 485 | 0.270 |
Why?
|
| Child | 23 | 2024 | 80510 | 0.270 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2021 | 581 | 0.270 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 1241 | 0.230 |
Why?
|
| Uganda | 5 | 2022 | 1353 | 0.210 |
Why?
|
| Nitrogen Dioxide | 2 | 2023 | 538 | 0.210 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15887 | 0.200 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1866 | 0.200 |
Why?
|
| Electronics | 2 | 2022 | 314 | 0.190 |
Why?
|
| Luminescence | 1 | 2022 | 110 | 0.190 |
Why?
|
| Nervous System Diseases | 2 | 2023 | 1659 | 0.190 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2023 | 128 | 0.180 |
Why?
|
| Child, Hospitalized | 1 | 2022 | 180 | 0.170 |
Why?
|
| Pediatrics | 3 | 2024 | 3604 | 0.170 |
Why?
|
| Respiration, Artificial | 5 | 2023 | 2712 | 0.170 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 270 | 0.170 |
Why?
|
| Receptor, Notch1 | 1 | 2023 | 517 | 0.170 |
Why?
|
| Work of Breathing | 1 | 2019 | 57 | 0.160 |
Why?
|
| Containment of Biohazards | 1 | 2019 | 39 | 0.160 |
Why?
|
| Pheochromocytoma | 1 | 2021 | 325 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 253 | 0.150 |
Why?
|
| Adrenal Glands | 1 | 2021 | 556 | 0.150 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 169 | 0.150 |
Why?
|
| Respiration | 2 | 2021 | 1653 | 0.140 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2017 | 97 | 0.140 |
Why?
|
| Cervical Vertebrae | 1 | 2023 | 978 | 0.140 |
Why?
|
| Humans | 42 | 2024 | 766011 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 666 | 0.130 |
Why?
|
| Hospitalization | 8 | 2023 | 10807 | 0.130 |
Why?
|
| Leukocytosis | 1 | 2017 | 248 | 0.130 |
Why?
|
| Phosphorus | 1 | 2017 | 337 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 239 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 568 | 0.130 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 730 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2017 | 284 | 0.120 |
Why?
|
| Adolescent | 15 | 2023 | 88804 | 0.120 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 713 | 0.110 |
Why?
|
| Health Resources | 2 | 2018 | 949 | 0.110 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2019 | 424 | 0.110 |
Why?
|
| Thyrotropin | 1 | 2017 | 835 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 3222 | 0.110 |
Why?
|
| Headache | 1 | 2021 | 1261 | 0.100 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 1525 | 0.100 |
Why?
|
| Infant, Newborn | 7 | 2023 | 26341 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2022 | 2185 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2132 | 0.100 |
Why?
|
| Anesthesia | 1 | 2023 | 1590 | 0.100 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2014 | 312 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2023 | 1539 | 0.090 |
Why?
|
| Infection Control | 1 | 2019 | 983 | 0.090 |
Why?
|
| Pandemics | 4 | 2024 | 8699 | 0.090 |
Why?
|
| Airway Management | 1 | 2014 | 297 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2022 | 42481 | 0.090 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2012 | 133 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2020 | 2120 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 2136 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 1603 | 0.090 |
Why?
|
| Plasmodium berghei | 1 | 2010 | 161 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 722 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2019 | 1760 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2206 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 12969 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 3110 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2156 | 0.080 |
Why?
|
| Vitamins | 1 | 2017 | 1632 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3782 | 0.070 |
Why?
|
| Antimalarials | 1 | 2015 | 912 | 0.070 |
Why?
|
| Boston | 1 | 2020 | 9341 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81522 | 0.070 |
Why?
|
| Male | 14 | 2023 | 363808 | 0.070 |
Why?
|
| Otolaryngology | 1 | 2014 | 698 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 754 | 0.070 |
Why?
|
| Oxygen | 3 | 2023 | 4242 | 0.070 |
Why?
|
| Aftercare | 2 | 2022 | 914 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2209 | 0.070 |
Why?
|
| Infant | 5 | 2022 | 36377 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10572 | 0.060 |
Why?
|
| Lung | 5 | 2023 | 10031 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 1999 | 0.060 |
Why?
|
| Young Adult | 7 | 2022 | 59870 | 0.060 |
Why?
|
| Patient Discharge | 3 | 2022 | 3466 | 0.060 |
Why?
|
| Respiratory Mechanics | 2 | 2019 | 719 | 0.060 |
Why?
|
| Intensive Care Units | 3 | 2023 | 3803 | 0.060 |
Why?
|
| Critical Care | 3 | 2021 | 2712 | 0.060 |
Why?
|
| Malaria, Falciparum | 1 | 2012 | 1074 | 0.060 |
Why?
|
| Calcium | 1 | 2017 | 5765 | 0.060 |
Why?
|
| Vitamin D | 1 | 2017 | 3272 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2012 | 1585 | 0.050 |
Why?
|
| United States | 8 | 2023 | 72914 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1805 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 13024 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3099 | 0.050 |
Why?
|
| Inflammation | 1 | 2023 | 10844 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2017 | 4425 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2014 | 2517 | 0.050 |
Why?
|
| Respiratory Therapy | 1 | 2023 | 124 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14645 | 0.050 |
Why?
|
| Nitrites | 1 | 2022 | 156 | 0.050 |
Why?
|
| Developing Countries | 1 | 2014 | 2912 | 0.050 |
Why?
|
| Metanephrine | 1 | 2021 | 25 | 0.050 |
Why?
|
| Mosquito Control | 1 | 2022 | 110 | 0.050 |
Why?
|
| Respiratory Protective Devices | 1 | 2021 | 47 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 3230 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8627 | 0.040 |
Why?
|
| Female | 12 | 2023 | 396159 | 0.040 |
Why?
|
| Nitrates | 1 | 2022 | 260 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9750 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2023 | 519 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2022 | 341 | 0.040 |
Why?
|
| HIV-1 | 1 | 2017 | 6944 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2023 | 1589 | 0.040 |
Why?
|
| Air Pressure | 1 | 2019 | 74 | 0.040 |
Why?
|
| Shock | 1 | 2021 | 316 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 30187 | 0.040 |
Why?
|
| Africa, Western | 1 | 2019 | 160 | 0.040 |
Why?
|
| Patient Isolation | 1 | 2019 | 101 | 0.040 |
Why?
|
| Adult | 7 | 2023 | 223109 | 0.040 |
Why?
|
| Masks | 1 | 2020 | 209 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5508 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2021 | 547 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18289 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2019 | 664 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 223058 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 855 | 0.030 |
Why?
|
| Pregnancy | 3 | 2022 | 30253 | 0.030 |
Why?
|
| Age Distribution | 1 | 2021 | 2865 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2019 | 677 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 877 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8878 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2022 | 1353 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2015 | 88 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2021 | 1068 | 0.030 |
Why?
|
| Ecuador | 1 | 2014 | 62 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 1168 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2017 | 671 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 74870 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65236 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1967 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 1845 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 2252 | 0.030 |
Why?
|
| Learning | 1 | 2022 | 1755 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22320 | 0.020 |
Why?
|
| Europe | 1 | 2019 | 3427 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 2586 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6321 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 452 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6307 | 0.020 |
Why?
|
| Culture | 1 | 2015 | 622 | 0.020 |
Why?
|
| HIV Infections | 1 | 2017 | 17531 | 0.020 |
Why?
|
| Obesity | 2 | 2023 | 13078 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2012 | 639 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3487 | 0.020 |
Why?
|
| Mice | 2 | 2020 | 81786 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10731 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8531 | 0.020 |
Why?
|
| Critical Illness | 1 | 2022 | 2746 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 1004 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26283 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41652 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3385 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8733 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2021 | 5997 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5596 | 0.020 |
Why?
|
| Animals | 3 | 2020 | 168721 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4772 | 0.020 |
Why?
|
| Logistic Models | 1 | 2021 | 13271 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 2501 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3655 | 0.020 |
Why?
|
| Health Care Reform | 1 | 2014 | 1259 | 0.010 |
Why?
|
| Parents | 1 | 2019 | 3589 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 171233 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2018 | 6251 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2022 | 54818 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18384 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2015 | 3137 | 0.010 |
Why?
|
| Poverty | 1 | 2015 | 2714 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 21507 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7876 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7476 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 14751 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7838 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15833 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20125 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20676 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 10389 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 40117 | 0.010 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_